Advanced Enzyme Technologies Limited — PPTs, 08-02-2025: Investor Presentation

Revenue grew by 16% quarter-on-quarter (q-o-q) to ₹1,691 million in Q3 FY25, driven by a 30% increase in EBITDA reaching ₹553 million. However, year-on-year (y-o-y) comparisons show a slight revenue increase of 5% from ₹1,609 million, while PAT fell by 9% to ₹389 million. The human nutrition segment, which contributes around 60% of total revenue, faced an 8% decline y-o-y but saw a 3% sequential growth. In contrast, the animal nutrition segment recorded a robust 22% y-o-y growth to ₹197 million. The industrial bio-processing segment experienced a significant boost, growing 36% y-o-y to ₹321 million. For the nine-month period, revenue was flat at ₹4,697 million compared to ₹4,661 million last year, with a stable PAT of ₹1,072 million. Advanced Enzymes continues to show resilience in key segments, suggesting a positive outlook for future growth despite some short-term challenges. Investors should keep an eye on the emerging trends in animal nutrition and industrial bio-processing.